Literature DB >> 22092854

Using optical coherence tomography for the longitudinal non-invasive evaluation of epidermal thickness in a murine model of chronic skin inflammation.

Rachel Silver1, Amy Helms, Wen Fu, Hui Wang, Doina Diaconu, Candace M Loyd, Andrew M Rollins, Nicole L Ward.   

Abstract

BACKGROUND: Non-invasive methods are desirable for longitudinal studies examining drug efficacy and disease resolution defined as decreases in epidermal thickness in mouse models of psoriasiform skin disease. This would eliminate the need for either sacrificing animals or collecting serial skin biopsies to evaluate changes in disease progression during an individual study. The quantitation of epidermal thickness using optical coherence tomography (OCT) provides an alternative to traditional histology techniques.
METHODS: Using the KC-Tie2 doxycycline-repressible psoriasiform skin disease mouse model, OCT imaging was completed on diseased back skin of adult KC-Tie2 (n = 3-4) and control (n = 3-4) mice, followed immediately by the surgical excision of the same region for histologic analyses. Animals were then treated with doxycycline to suppress transgene expression and to reverse the skin disease and additional OCT images and tissues were collected 2 and 4 weeks following. Epidermal thickness was measured using OCT and histology.
RESULTS: Optical coherence tomography and histology both demonstrated that KC-Tie2 mice had significantly thicker epidermis (~4-fold; P < 0.0001) than control animals. By 2 weeks following gene repression, decreases in epidermal thickness were observed using both OCT and histology, and were sustained through 4 weeks. Correlation analyses between histology and OCT values at all time points and in all animals revealed high significance (R(2) = 0.78); with correlation being highest in KC-Tie2 mice (R(2) = 0.92) compared to control animals (R(2) = 0.16).
CONCLUSION: Non-invasive OCT imaging provided similar values as those collected using standard histologic measures in thick skin of KC-Tie2 mice but became less reliable in thinner control mouse skin, possibly reflecting limitations in resolution of OCT. Future advances in resolution of OCT may improve and allow greater accuracy of epidermal thickness measurements.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22092854      PMCID: PMC3319809          DOI: 10.1111/j.1600-0846.2011.00558.x

Source DB:  PubMed          Journal:  Skin Res Technol        ISSN: 0909-752X            Impact factor:   2.365


  29 in total

1.  Depletion of antigen-presenting cells by clodronate liposomes reverses the psoriatic skin phenotype in KC-Tie2 mice.

Authors:  N L Ward; C M Loyd; J A Wolfram; D Diaconu; C M Michaels; T S McCormick
Journal:  Br J Dermatol       Date:  2011-04       Impact factor: 9.302

Review 2.  Applications of optical coherence tomography in dermatology.

Authors:  Thilo Gambichler; Georg Moussa; Michael Sand; Daniel Sand; Peter Altmeyer; Klaus Hoffmann
Journal:  J Dermatol Sci       Date:  2005-08-31       Impact factor: 4.563

3.  Optical coherence tomography of skin for measurement of epidermal thickness by shapelet-based image analysis.

Authors:  Jesse Weissman; Tom Hancewicz; Peter Kaplan
Journal:  Opt Express       Date:  2004-11-15       Impact factor: 3.894

4.  Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor.

Authors:  Ken Miyoshi; Mikiro Takaishi; Kimiko Nakajima; Mitsunori Ikeda; Takashi Kanda; Masahito Tarutani; Tatsuo Iiyama; Naoki Asao; John DiGiovanni; Shigetoshi Sano
Journal:  J Invest Dermatol       Date:  2010-09-02       Impact factor: 8.551

5.  Comparison of histometric data obtained by optical coherence tomography and routine histology.

Authors:  Thilo Gambichler; Stefanie Boms; Markus Stücker; Alexander Kreuter; Michael Sand; Georg Moussa; Peter Altmeyer; Klaus Hoffmann
Journal:  J Biomed Opt       Date:  2005 Jul-Aug       Impact factor: 3.170

6.  The beneficial effect of blocking Kv1.3 in the psoriasiform SCID mouse model.

Authors:  Amos Gilhar; Reuven Bergman; Bedia Assay; Yehuda Ullmann; Amos Etzioni
Journal:  J Invest Dermatol       Date:  2010-08-26       Impact factor: 8.551

7.  Validation of optical coherence tomography in vivo using cryostat histology.

Authors:  T Gambichler; G Moussa; P Regeniter; C Kasseck; M R Hofmann; F G Bechara; M Sand; P Altmeyer; K Hoffmann
Journal:  Phys Med Biol       Date:  2007-01-31       Impact factor: 3.609

Review 8.  Newer technologies/techniques and tools in the diagnosis of melanoma.

Authors:  Jitendrakumar K Patel; Sailesh Konda; Oliver A Perez; Sadegh Amini; George Elgart; Brian Berman
Journal:  Eur J Dermatol       Date:  2008-10-27       Impact factor: 3.328

9.  Topical application of anti-angiogenic peptides based on pigment epithelium-derived factor can improve psoriasis.

Authors:  Riichiro Abe; Sho-ichi Yamagishi; Yasuyuki Fujita; Daichi Hoshina; Mikako Sasaki; Kazuo Nakamura; Takanori Matsui; Tadamichi Shimizu; Richard Bucala; Hiroshi Shimizu
Journal:  J Dermatol Sci       Date:  2010-01-08       Impact factor: 4.563

Review 10.  Mouse models of psoriasis.

Authors:  Johann E Gudjonsson; Andrew Johnston; Melissa Dyson; Helgi Valdimarsson; James T Elder
Journal:  J Invest Dermatol       Date:  2007-04-12       Impact factor: 8.551

View more
  4 in total

1.  Optical coherence tomography based microangiography for quantitative monitoring of structural and vascular changes in a rat model of acute uveitis in vivo: a preliminary study.

Authors:  Woo June Choi; Kathryn L Pepple; Zhongwei Zhi; Ruikang K Wang
Journal:  J Biomed Opt       Date:  2015-01       Impact factor: 3.170

2.  Semisupervised representative learning for measuring epidermal thickness in human subjects in optical coherence tomography by leveraging datasets from rodent models.

Authors:  Yubo Ji; Shufan Yang; Kanheng Zhou; Jie Lu; Ruikang Wang; Holly R Rocliffe; Antonella Pellicoro; Jenna L Cash; Chunhui Li; Zhihong Huang
Journal:  J Biomed Opt       Date:  2022-08       Impact factor: 3.758

3.  Case report: Optical coherence tomography for monitoring biologic therapy in psoriasis and atopic dermatitis.

Authors:  Linh Ha-Wissel; Handan Yasak; Robert Huber; Detlef Zillikens; Ralf J Ludwig; Diamant Thaçi; Jennifer E Hundt
Journal:  Front Med (Lausanne)       Date:  2022-09-27

4.  Chronic skin-specific inflammation promotes vascular inflammation and thrombosis.

Authors:  Yunmei Wang; Huiyun Gao; Candace M Loyd; Wen Fu; Doina Diaconu; Shijian Liu; Kevin D Cooper; Thomas S McCormick; Daniel I Simon; Nicole L Ward
Journal:  J Invest Dermatol       Date:  2012-05-10       Impact factor: 8.551

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.